Last reviewed · How we verify
Artesunate 4
Artesunate 4 is a Small molecule drug developed by University of Oxford. It is currently FDA-approved.
Artesunate is a small molecule medication with an unknown mechanism of action, used to treat conditions such as malaria, uncomplicated Plasmodium falciparum malaria, and anemia. It is available under various brand names, including Artecom, and has been studied in clinical trials for its efficacy and bioequivalence in different formulations.
At a glance
| Generic name | Artesunate 4 |
|---|---|
| Sponsor | University of Oxford |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults (PHASE1)
- OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa (PHASE4)
- Dose-Escalation Study of Artesunate Patients With IPF (PHASE1)
- A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension (PHASE1)
- Safety of Antimalarials in the FIRst trimEster (PHASE3)
- A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs. (PHASE3)
- Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) (PHASE2)
- In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Artesunate 4 CI brief — competitive landscape report
- Artesunate 4 updates RSS · CI watch RSS
- University of Oxford portfolio CI
Frequently asked questions about Artesunate 4
What is Artesunate 4?
Who makes Artesunate 4?
What development phase is Artesunate 4 in?
Related
- Manufacturer: University of Oxford — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing